(Q44393916)

2 December 2017

title

Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma (English)

1 reference

2 December 2017

4

1 reference

2 December 2017

5

1 reference

2 December 2017

Shih-Hung Yang

1

1 reference

2 December 2017

Long-Wei Lin

series ordinal

2

1 reference

2 December 2017

Yu-Jen Fang

series ordinal

3

1 reference

2 December 2017

publication date

3 May 2011

1 reference

2 December 2017

1 reference

2 December 2017

volume

91

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

291-294

1 reference

Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1238-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1238-8

Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1238-8

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1238-8

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1238-8

10.1007/S00277-011-1238-8

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference